Arvinas Tech Stack

Arvinas uses 8 technology products and services including WordPress, Microsoft PowerPoint, Google Font API, and more. Explore Arvinas's tech stack below.

  • WordPress
    Content Management System
  • Microsoft PowerPoint
    Editors
  • Google Font API
    Font Scripts
  • ADP
    Human Resource Management System
  • Modernizr
    Javascript Libraries
  • Amazon Web Services
    Platform As A Service
  • Android
    Programming Languages
  • FedEx
    Transportation And Fleet Management

Media & News

Arvinas's Email Address Formats

Arvinas uses at least 4 format(s):
Arvinas Email FormatsExamplePercentage
first.middlelast@arvinas.comJohn.MichaelDoe@arvinas.com
29%
first.middle@arvinas.comJohn.Michael@arvinas.com
28%
last.first@arvinas.comDoe.John@arvinas.com
29%
first_l@arvinas.comJohn_D@arvinas.com
14%

Frequently Asked Questions

Where is Arvinas's headquarters located?

Minus sign iconPlus sign icon
Arvinas's main headquarters is located at 395 Winchester Ave. 5 Science Park New Haven, Connecticut 06511 US. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is Arvinas's phone number?

Minus sign iconPlus sign icon
You can contact Arvinas's main corporate office by phone at +1-203-535-1456. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Arvinas's stock symbol?

Minus sign iconPlus sign icon
Arvinas is a publicly traded company; the company's stock symbol is ARVN.

What is Arvinas's official website and social media links?

Minus sign iconPlus sign icon
Arvinas's official website is arvinas.com and has social profiles on LinkedIn.

How much revenue does Arvinas generate?

Minus sign iconPlus sign icon
As of March 2024, Arvinas's annual revenue reached $75M.

What is Arvinas's SIC code NAICS code?

Minus sign iconPlus sign icon
Arvinas's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Arvinas have currently?

Minus sign iconPlus sign icon
As of March 2024, Arvinas has approximately 438 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Commercial Officer: J. N.Chief Medical Officer: R. P.Chief Medical Officer: N. B.. Explore Arvinas's employee directory with LeadIQ.

What industry does Arvinas belong to?

Minus sign iconPlus sign icon
Arvinas operates in the Biotechnology Research industry.

What technology does Arvinas use?

Minus sign iconPlus sign icon
Arvinas's tech stack includes WordPressMicrosoft PowerPointGoogle Font APIADPModernizrAmazon Web ServicesAndroidFedEx.

What is Arvinas's email format?

Minus sign iconPlus sign icon
Arvinas's email format typically follows the pattern of first.middlelast@arvinas.com. Find more Arvinas email formats with LeadIQ.

How much funding has Arvinas raised to date?

Minus sign iconPlus sign icon
As of March 2024, Arvinas has raised $350M in funding. The last funding round occurred on Nov 27, 2023.

When was Arvinas founded?

Minus sign iconPlus sign icon
Arvinas was founded in 2013.
Arvinas

Arvinas

Biotechnology ResearchConnecticut, United States201-500 Employees

Arvinas is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC® Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC® targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. In addition to its robust preclinical pipeline of PROTAC® protein degraders against validated and “undruggable” targets, the company has two clinical-stage programs: ARV-110 for the treatment of men with metastatic castrate-resistant prostate cancer; and ARV-471 for the treatment of patients with locally advanced or metastatic ER+/HER2- breast cancer. For more information, visit www.arvinas.com.
Community Guidelines: http://bit.ly/ArvinasCG

Section iconCompany Overview

Headquarters
395 Winchester Ave. 5 Science Park New Haven, Connecticut 06511 US
Phone number
+1-203-535-1456
SIC Code
2834 - Pharmaceutical Preparations
Stock Symbol
ARVN
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
201-500

Section iconFunding & Financials

  • $350M

    Arvinas has raised a total of $350M of funding over 4 rounds. Their latest funding round was raised on Nov 27, 2023.

  • $50M$100M

    Arvinas's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $350M

    Arvinas has raised a total of $350M of funding over 4 rounds. Their latest funding round was raised on Nov 27, 2023.

  • $50M$100M

    Arvinas's revenue is in the range of $50M$100M

© LeadIQ, Inc. All rights reserved.